ESSA Pharma
(NASDAQ) EPIX
ESSA Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$135.75K
Net Income (TTM)
$25.27M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
EPIX News
EPIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ESSA Pharma
Industry
Biotechnology
Sector
Health CareEmployees
35
CEO
David R. Parkinson, MD, PhD
Website
www.essapharma.comHeadquarters
Vancouver, BC V5Z 1K5, CA
EPIX Financials
Key Financial Metrics (TTM)
Gross Margin
3%
Operating Margin
-219%
Net Income Margin
-186%
Return on Equity
-22%
Return on Capital
-27%
Return on Assets
-23%
Earnings Yield
N/A
Dividend Yield
840.47%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$90.68K
Operating Income
$34.42M
EBITDA
$28.45M
Operating Cash Flow
$22.72M
Capital Expenditure
$0.00
Free Cash Flow
$22.72M
Cash & ST Invst.
$126.76M
Total Debt
$329.26K
ESSA Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$16.38K
+27.7%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
35
N/A
Net Income
$4.00M
+44.7%
EBITDA
$4.98M
+30.9%
Quarterly Fundamentals
Net Cash
$109.62M
-15.9%
Accounts Receivable
$527.15K
+187.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-22.86%
N/A
Return on Invested Capital
-27.32%
N/A
Free Cash Flow
$4.20M
+26.9%
Operating Cash Flow
$4.20M
+26.9%